Johnson & Johnson to acquire Proteologix in $850m deal to enhance immunology portfolio

businessnewstoday- May 17, 2024 0

Johnson & Johnson (NYSE: JNJ) has entered into a definitive agreement to acquire Proteologix, Inc., a leading biotechnology company specializing in the development of bispecific ... Read More

Novartis to expand oncology portfolio with acquisition of Mariana Oncology

businessnewstoday- May 2, 2024 0

Novartis has announced a significant move in the oncology sector with its agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts. ... Read More

ONO Pharmaceutical to acquire Deciphera Pharmaceuticals in $2.4bn deal

businessnewstoday- April 30, 2024 0

ONO Pharmaceutical, Co., Ltd., has entered into a definitive agreement to acquire all outstanding shares of Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), for $25.60 per share ... Read More

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9bn in strategic expansion

businessnewstoday- April 11, 2024 0

In a major development in the biotechnology industry, Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Alpine Immune Sciences, Inc. (Nasdaq: ALPN) have announced a definitive agreement ... Read More

Gilead Sciences completes $4.3bn acquisition of CymaBay Therapeutics to enhance liver disease portfolio

businessnewstoday- March 23, 2024 0

Gilead Sciences, Inc. (Nasdaq: GILD) has officially announced the successful acquisition of CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for a staggering $4.3 billion, a move that ... Read More

AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development

businessnewstoday- March 19, 2024 0

In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a pioneer in the development of ... Read More

AstraZeneca to acquire Amolyt Pharma in $1.05bn deal to expand rare disease portfolio

businessnewstoday- March 15, 2024 0

AstraZeneca has announced a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on novel treatments for rare endocrine diseases, in a deal ... Read More

Gilead Sciences to acquire CymaBay Therapeutics to enhance liver disease portfolio

businessnewstoday- February 14, 2024 0

In a significant move within the biopharmaceutical industry, Gilead Sciences, Inc. (Nasdaq: GILD) has confirmed its acquisition of CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for a ... Read More

Jazz Pharmaceuticals to acquire Redx Pharma’s KRAS inhibitor program to expand oncology pipeline

businessnewstoday- February 7, 2024 0

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Redx Pharma plc (AIM: REDX) have entered into a definitive agreement, marking a significant milestone in the development of ... Read More

Novartis announces takeover bid for MorphoSys AG to boost oncology pipeline

businessnewstoday- February 6, 2024 0

In a significant move within the pharmaceutical industry, Novartis has entered into an agreement to launch a voluntary public takeover offer to acquire MorphoSys AG, ... Read More